The PE ratio for Idexx Laboratories stock stands at 42.04 as of Feb 21, 2025. The calculation is based on the latest EPS of $10.77 and the stock price of $452.77 per share. A decrease of 10% has been observed in the PE ratio compared to its average of 46.6 of the last four quarters.
Over the last ten years, the average PE ratio of Idexx Laboratories has been 52.77. The current 42.04 P/E ratio is 20% lower than the historical average. Looking back at the last ten years, IDXX's PE ratio peaked in the Dec 2021 quarter at 75.34, with a price of $658.46 and an EPS of $8.74. The Jun 2015 quarter marked the lowest point at 33.58, with a price of $64.14 and an EPS of $1.91.
Maximum annual increase: 39.49% in 2020
Maximum annual decrease: -33.32% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 38.39 | -29.66% | $413.44 | $10.77 |
2023 | 54.58 | 8.64% | $555.05 | $10.17 |
2022 | 50.24 | -33.32% | $407.96 | $8.12 |
2021 | 75.34 | 2.8% | $658.46 | $8.74 |
2020 | 73.29 | 39.49% | $499.87 | $6.82 |
2019 | 52.54 | 22.59% | $261.13 | $4.97 |
2018 | 42.86 | -17.78% | $186.02 | $4.34 |
2017 | 52.13 | 9.79% | $156.38 | $3 |
2016 | 47.48 | 34.77% | $117.27 | $2.47 |
2015 | 35.23 | -13.5% | $72.92 | $2.07 |
2014 | 40.73 | 35.54% | $74.14 | $1.82 |
2013 | 30.05 | 4.92% | $53.19 | $1.77 |
2012 | 28.64 | 6.43% | $46.4 | $1.62 |
2011 | 26.91 | -4.37% | $38.48 | $1.43 |
2010 | 28.14 | 9.49% | $34.61 | $1.23 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 38.39 | -20.44% | $413.44 | $10.77 |
Sep 2024 | 48.25 | 0.92% | $505.22 | $10.47 |
Jun 2024 | 47.81 | -7.65% | $487.2 | $10.19 |
Mar 2024 | 51.77 | -5.15% | $539.93 | $10.43 |
Dec 2023 | 54.58 | 23.71% | $555.05 | $10.17 |
Sep 2023 | 44.12 | -16.28% | $437.27 | $9.91 |
Jun 2023 | 52.7 | -11.47% | $502.23 | $9.53 |
Mar 2023 | 59.53 | 18.49% | $500.08 | $8.4 |
Dec 2022 | 50.24 | 22.75% | $407.96 | $8.12 |
Sep 2022 | 40.93 | -8.39% | $325.8 | $7.96 |
Jun 2022 | 44.68 | -29.35% | $350.73 | $7.85 |
Mar 2022 | 63.24 | -16.06% | $547.06 | $8.65 |
Dec 2021 | 75.34 | 7.46% | $658.46 | $8.74 |
Sep 2021 | 70.11 | -5.42% | $621.9 | $8.87 |
Jun 2021 | 74.13 | 19.68% | $631.55 | $8.52 |
IDXX's current PE ratio is lower than its 3, 5 and 10-year averages.
In comparison to its peer stocks ABT and TMO, IDXX's PE ratio is higher.
Stock name | PE ratio | Market cap |
---|---|---|
HSIC Henry Schein Inc | 31.4 | $9.63B |
TMO Thermo Fisher Scientific Inc | 32.12 | $200.91B |
ABT Abbott Laboratories | 40.88 | $234.01B |
IDXX Idexx Laboratories Inc | 42.04 | $36.82B |
NEOG Neogen Corp | N/A | $2.18B |
WOOF Petco Health & Wellness Company Inc | N/A | $912.13M |
The price to earnings ratio for IDXX stock as of Feb 21, 2025, stands at 42.04.
The 3-year average price to earnings ratio for IDXX stock is 49.69.
The 5-year average price to earnings ratio for IDXX stock is 56.37.
The highest quarterly PE ratio in the last ten years has been 75.34 and it was in the Dec 2021 quarter.
IDXX's current price to earnings ratio is 20% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Feb 21, 2025), Idexx Laboratories's share price is $452.77. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $10.77. Therefore, Idexx Laboratories's PE ratio for today is 42.04. PE RATIO(42.04) = STOCK PRICE($452.77) / TTM EPS($10.77)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.